# OnCo record serabelisib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/serabelisib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "serabelisib" ;
  schema:name "Serabelisib"@en ;
  schema:description "Serabelisib is an experimental small-molecule drug from Faeth Therapeutics in phase 2 trials for HR-positive / HER2-negative breast cancer and endometrial cancer, aimed at PIK3CA / PI3K-alpha."@en ;
  schema:url <https://onco.cc/drugs/serabelisib/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=FTH-001>, <https://www.faeththerapeutics.com> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "small molecule" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/endometrial/> ;
  onco:targets <https://onco.cc/targets/pik3ca/> ;
  onco:companies <https://onco.cc/companies/takeda/>, <https://onco.cc/companies/celcuity/> ;
  onco:trials <https://onco.cc/trials/nct06463028/>, <https://onco.cc/trials/nct07558733/> .